On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Tuberous Sclerosis Complex Research

TopicLeading institutions, researchers & key papers

Tuberous Sclerosis Complex Research is a topic indexed in ScholarIQ from OpenAlex.

What is known about Tuberous Sclerosis Complex Research?

ScholarIQrecord summary

This cluster of papers focuses on Tuberous Sclerosis Complex (TSC) and related disorders, including Lymphangioleiomyomatosis and Angiomyolipoma. It covers various aspects such as genetic mutations, neurological manifestations, use of mTOR inhibitors, diagnostic criteria, and the role of hamartin and tuberin proteins. Additionally, it explores the association with epilepsy and cognitive impairment.

How many works does Tuberous Sclerosis Complex Research have?

ScholarIQindexed works

Tuberous Sclerosis Complex Research has 113 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Tuberous Sclerosis Complex Research?

ScholarIQopenalex

The OpenAlex for Tuberous Sclerosis Complex Research is on the source record.

What are the most-cited papers on Tuberous Sclerosis Complex Research?

ScholarIQmost cited works
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Hope Northrup, Darcy A. Krueger, Hope Northrup, Darcy A. Krueger, Steven L. Roberds, Katie Smith, Julian R. Sampson, Bruce R. Korf, David J. Kwiatkowski, David Mowat, Mark Nellist, Hope Northrup, Sue Povey, Petrus de Vries, Anna W. Byars, David Dunn, Kevin C. Ess, Dena Hook, Anna Jansen, Bryan H. King, Mustafa Şahin, Vicky Whittemore, Elizabeth A. Thiele, E. Martina Bebin, Harry T. Chugani, Peter B. Crino, Paolo Curatolo, Greg Holmes, Rima Nabbout, Finbar O’Callaghan, James W. Wheless, Joyce Y. Wu, Thomas N. Darling, Edward W. Cowen, Elizabeth S. Gosnell, Adelaide A. Hebert, Greg Mlynarczyk, Keyomaurs Soltani, Joyce Teng, Mari Wataya‐Kaneda, Patricia M. Witman, Chris Kingswood, John J. Bissler, Klemens Budde, John C. Hulbert, Lisa M. Guay‐Woodford, Julian R. Sampson, Matthias Sauter, Bernard Zonneberg, Sergiusz Jóźwiak, Ute Bartels, Moncef Berhouma, David Neal Franz, Mary Kay Koenig, Darcy A. Krueger, E. Steve Roach, Jonathan Roth, Henry E. Wang, Howard L. Weiner, Francis X. McCormack, Khalid F. Almoosa, Alan S. Brody, Charles D. Burger, Vincent Cottin, Geraldine A. Finlay, Jennifer Glass, Elizabeth P. Henske, Simon R. Johnson, Robert M. Kotloff, D. K. Lynch, Joel Moss, Karen L. Smith, Jay Rhu, Angelo Taveira Da Silva, Lisa R. Young, Timothy K. Knilans, Robert B. Hinton, Ashwin Prakash, Robb L. Romp, Arun D. Singh, Ashish DebRoy, Pei‐Lung Chen, Steven Sparagana, Michael Frost
Pediatric Neurology. 20131,516 CitationsOPEN ACCESS
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
John J. Bissler, Francis X. McCormack, Lisa R. Young, Jean Elwing, Gail Chuck, Jennifer Leonard, Vincent J. Schmithorst, Tal Laor, Alan S. Brody, Judy A. Bean, Shelia Salisbury, David Neal Franz
New England Journal of Medicine. 20081,274 CitationsOPEN ACCESS
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska, Bernard A. Zonnenberg, Michael Frost, Е. Д. Белоусова, Matthias Sauter, Norio Nonomura, Susanne Brakemeier, Petrus J. de Vries, Vicky Whittemore, David Chen, Tarek Sahmoud, Gaurav Shah, Jeremie Lincy, David Lebwohl, Klemens Budde
The Lancet. 2013888 Citations
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Darcy A. Krueger, Hope Northrup, Hope Northrup, Darcy A. Krueger, Steven L. Roberds, Katie Smith, Julian R. Sampson, Bruce R. Korf, David J. Kwiatkowski, David Mowat, Mark Nellist, Hope Northrup, Sue Povey, Petrus de Vries, Anna W. Byars, David Dunn, Kevin C. Ess, Dena Hook, Anna Jansen, Bryan H. King, Mustafa Şahin, Vicky Whittemore, Elizabeth A. Thiele, E. Martina Bebin, Harry T. Chugani, Peter B. Crino, Paolo Curatolo, Greg Holmes, Rima Nabbout, Finbar O’Callaghan, James W. Wheless, Joyce Y. Wu, Thomas N. Darling, Edward W. Cowen, Elizabeth S. Gosnell, Adelaide A. Hebert, Greg Mlynarczyk, Keyomaurs Soltani, Joyce Teng, Mari Wataya‐Kaneda, Patricia M. Witman, Chris Kingswood, John J. Bissler, Klemens Budde, John C. Hulbert, Lisa M. Guay‐Woodford, Julian R. Sampson, Matthias Sauter, Bernard Zonneberg, Sergiusz Jóźwiak, Ute Bartels, Moncef Berhouma, David Neal Franz, Mary Kay Koenig, Darcy A. Krueger, E. Steve Roach, Jonathan Roth, Henry E. Wang, Howard L. Weiner, Francis X. McCormack, Khalid F. Almoosa, Alan S. Brody, Charles D. Burger, Vincent Cottin, Geraldine A. Finlay, Jennifer Glass, Elizabeth P. Henske, Simon R. Johnson, Robert M. Kotloff, D. K. Lynch, Joel Moss, Karen L. Smith, Jay Rhu, Angelo Taveira Da Silva, Lisa R. Young, Timothy K. Knilans, Robert B. Hinton, Ashwin Prakash, Robb L. Romp, Arun D. Singh, Ashish DebRoy, Pei‐Lung Chen, Steven Sparagana, Michael Frost
Pediatric Neurology. 2013862 CitationsOPEN ACCESS
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Jacqueline A. French, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Dennis Dlugos, Noah Berkowitz, Maurizio Voi, Séverine Peyrard, Diana Pelov, David Neal Franz
The Lancet. 2016754 CitationsOPEN ACCESS

Where is Tuberous Sclerosis Complex Research research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Tuberous Sclerosis Complex Research is open access?

ScholarIQopen access share
53%OPEN ACCESS
Gold
7%
Green
7%
Hybrid
20%
Bronze
20%
Closed
47%

Related on ScholarIQ

470M+ articles · free account